SunTrust Banks Reiterates $82.00 Price Target for Express Scripts (ESRX)
Several other research firms also recently commented on ESRX. BidaskClub upgraded shares of Express Scripts from a hold rating to a buy rating in a report on Thursday. Maxim Group increased their target price on shares of Express Scripts from $78.00 to $87.00 and gave the stock a buy rating in a report on Thursday. ValuEngine raised Express Scripts from a hold rating to a buy rating in a research note on Monday, December 4th. TheStreet raised Express Scripts from a c+ rating to a b- rating in a research note on Monday, December 4th. Finally, Sanford C. Bernstein raised shares of Express Scripts from an underperform rating to a market perform rating in a research report on Wednesday, December 6th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Express Scripts presently has a consensus rating of Hold and an average target price of $74.40.
Shares of Express Scripts (NASDAQ:ESRX) traded up $2.53 during mid-day trading on Thursday, hitting $71.55. 8,786,136 shares of the stock were exchanged, compared to its average volume of 4,094,484. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The company has a market capitalization of $40,523.99, a price-to-earnings ratio of 10.46, a PEG ratio of 1.06 and a beta of 0.88. Express Scripts has a twelve month low of $55.80 and a twelve month high of $73.42.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.90. The business had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.74 earnings per share. equities analysts predict that Express Scripts will post 7.02 EPS for the current year.
In other news, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Timothy C. Wentworth purchased 8,000 shares of the stock in a transaction dated Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the completion of the acquisition, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. Corporate insiders own 0.68% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Dodge & Cox lifted its stake in shares of Express Scripts by 25.7% in the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares during the last quarter. Pzena Investment Management LLC bought a new stake in shares of Express Scripts during the 2nd quarter worth approximately $181,234,000. Northern Trust Corp lifted its stake in shares of Express Scripts by 12.2% during the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after acquiring an additional 1,206,980 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Express Scripts by 23.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after acquiring an additional 996,816 shares during the last quarter. Finally, Veritas Asset Management LLP raised its position in Express Scripts by 13.2% during the 2nd quarter. Veritas Asset Management LLP now owns 8,192,572 shares of the company’s stock valued at $523,014,000 after purchasing an additional 952,249 shares in the last quarter. 88.44% of the stock is currently owned by institutional investors.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with Analyst Ratings Network's FREE daily email newsletter.